A Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether NK012 is safe and effective in the
treatment of advanced and metastatic triple negative breast cancer.